This inventor holds 4 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignee: Genfit. Active years: 2014-2026.
Location History:
- Frelinghein, FR (2014)
- Frelinghien, FR (2015 - 2024)
Company Filing History:
Years Active: 2014-2026
Title: Karine Bertrand: Innovator in Pharmaceutical Sciences
Introduction
Karine Bertrand is a notable inventor based in Frelinghien, France. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel compounds with therapeutic applications. With a total of 4 patents to her name, her work is paving the way for advancements in treating various metabolic and inflammatory diseases.
Latest Patents
Among her latest patents is the invention of elafibranor salts, which relates to the salts of elafibranor. Another significant patent involves 1,3-diphenylpropane derivatives, which includes pharmaceutical compositions and their therapeutic uses. These compounds exhibit intrinsic PPAR agonist properties, making them particularly valuable in treating conditions associated with metabolic syndrome, such as steatohepatitis, type 2 diabetes, and neurodegenerative disorders like Alzheimer's and Parkinson's diseases.
Career Highlights
Karine Bertrand is currently associated with Genfit, a company focused on developing innovative therapies for metabolic diseases. Her work at Genfit has been instrumental in advancing research and development in this critical area of healthcare.
Collaborations
She collaborates with talented individuals such as Alice Roudot and Patrice Rool, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Karine Bertrand's contributions to pharmaceutical sciences through her patents and collaborations highlight her role as a leading inventor in the field. Her work continues to impact the treatment of significant health challenges, showcasing the importance of innovation in medicine.